TuHURA BIOSCIENCES, INC./NV Finance Lease, Principal Payments
TuHURA BIOSCIENCES, INC./NV (HURA) reported Finance Lease, Principal Payments of $21.89 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV finance lease, principal payments for the quarter ending 2026-06-30 was $11.05K.
- TuHURA BIOSCIENCES, INC./NV finance lease, principal payments for the quarter ending 2026-03-31 was $10.85K.
- TuHURA BIOSCIENCES, INC./NV finance lease, principal payments for the quarter ending 2025-12-31 was $10.64K.
- TuHURA BIOSCIENCES, INC./NV finance lease, principal payments for the quarter ending 2025-09-30 was $43.67K.
- TuHURA BIOSCIENCES, INC./NV finance lease, principal payments for fiscal 2025 was $54.31K.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $21.89K 10-Q · filed 2026-08-14 | $32.54K derived: sum of 3 quarters · filed 2026-08-14 | $76.21K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $10.85K 10-Q · filed 2026-05-15 | $21.49K derived: sum of 2 quarters · filed 2026-05-15 | $65.16K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | $10.64K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $54.31K derived: sum of 2 quarters · filed 2026-03-31 | $54.31K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $43.67K 10-Q · filed 2025-11-14 | $43.67K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |